Literature DB >> 8623507

Antioxidant agents and colorectal carcinogenesis: role of beta-carotene, vitamin E and vitamin C.

G Pappalardo1, A Guadalaxara, G Maiani, G Illomei, M Trifero, F M Frattaroli, S Mobarhan.   

Abstract

In consideration of findings reported in the literature and of our study, we examined the correlation between antioxidants (beta-carotene, vitamin C, vitamin E) and colorectal carcinogenesis. Although diagnostic progress has been made in the last decades, no significant improvements in death rates have been achieved in the western world. Exogenous factors might be responsible for a complex alteration process of might be responsible for a complex alteration process of normal colonic mucosa into adenoma and carcinoma. Free radicals and reactive oxygen metabolites, due to increased production or to reduced inactivation, following a decrease in the antioxidant burden in the mucosa, might cause damage to DNA, thereby resulting in genetic alterations. This might represent the cause of the transformation process: normal mucosa --> adenoma --> carcinoma. In a prospective study, we observed a reduction of beta-carotene levels in normal colonic mucosa in patients with polyps and colorectal cancer. We also showed that beta-carotene supplementation raises levels of this micronutrient in the colonic mucosa of these patients. Findings from the literature and our trials show a significant decrease in the antioxidant capacity of colorectal mucosa in patients affected by colorectal cancer, although there is a significant interindividual variability. Such results suggest a possible chemopreventive role of antioxidant agents in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623507     DOI: 10.1177/030089169608200102

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  1 in total

1.  Effect of cholesterol levels on villous histology in colonic adenomas.

Authors:  J Houghton; G G Lardieri; N P Zauber; K H Kim; G Cable
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.